We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksC4XD.L Share News (C4XD)

  • There is currently no data for C4XD

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

EXECUTIVE CHANGES: James Fisher names new CFO; Lekoil loses new chair

Tue, 20th Apr 2021 15:36

(Alliance News) - The following is a round-up of London-listed company director and manager changes announced on Tuesday and not separately reported by Alliance News:

----------

James Fisher & Sons PLC - Barrow In Furness, Cumbria-based marine services - Hires Duncan Kennedy as chief financial officer and executive director, starting May 4. Kennedy replaces Stuart Kilpatrick, who as previously announced will step down at the April 29 annual general meeting. Kennedy joins from BTG PLC, where he was CFO until the former FTSE 250 healthcare firm was acquired by Boston Scientific Corp in 2019.

----------

IDE Group Holdings PLC - Croydon-based network, cloud and IT managed services provider - Hires David Templeman as CFO and executive director, starting immediately. Templeman was CFO of Orbian, a provider of supply chain finance originally set up as a joint venture between Citigroup Inc and SAP SE.

----------

Lekoil Ltd - oil and gas exploration and production in Nigeria - Michael Ajukwu and Mark Simmonds step down as non-executive directors, both from Wednesday. Ajukwu was made chair only in January, so Anthony Hawkins will step up to interim chair until a permanent replacement is found. In resigning, Lekoil said that Ajukwu noted "a fundamental misalignment of objectives amongst the shareholders of Lekoil Nigeria" and said he believes new directors are required to address the issue. Lekoil appointed two new non-executive directors. Marco D'Attanasio is chief investment officer at London-based investment management firm Hadron Capital and is on the board of London-listed cryptocurrency miner Argo Blockchain PLC. Al Tindall is senior counsel at Hardwick Law Firm LLC in the US.

----------

Red Emperor Resources NL - AIM cash shell - Proposes Allan Mulligan and Robert Mosig as non-executive directors and Shane Hibbird as consulting geologist, while also requesting cancellation of Red Emperor shares from trading on AIM. Delisting from AIM is intended to facilitate Red Emperor's proposed acquisition of Great Northern Palladium Pty Ltd, due to the differing rules of the ASX exchange in Sydney and AIM in London. Great Northern Palladium owns 80%, and holds an option over the remaining 20%, of Panton Sill Pty Ltd, the holder of the Panton platinum group metals project in Kimberley, Western Australia. New director Mulligan worked at Lonmin PLC for 14 years and was Lonmin's representative on the board of Platinum Australia Ltd, a previous owner of the Panton project. Mosig is chief executive officer of Caeneus Minerals Ltd. The AIM delisting will occur on May 18, but Red Emperor hopes to rejoin AIM once the acquisition is complete.

----------

Antofagasta PLC - copper miner in Chile - Hires Maria Eugenia Parot as independent non-executive director, effective immediately. Parot retired as vice president of Latin America for mining consultants Golder Associates in 2020.

----------

C4X Discovery Holdings PLC - Manchester-based developer of drug discovery engine - Hires Simon Harford as non-executive director, effective immediately. Harford is CFO of Albireo Pharma Inc, a NASDAQ-listed biotech company.

----------

Thor Mining PLC - diverse mining projects in Australia and the US - Promotes Exploration Manager Nicole Galloway Warland to board as managing director, effective immediately. Mick Billing will relinquish the role of CEO but remain executive chair.

----------

By Tom Waite; thomaslwaite@alliancenews.com

Copyright 2021 Alliance News Limited. All Rights Reserved.

More News
7 May 2020 17:57

C4X Discovery Raises GBP1.6 Million Via Share Placing

C4X Discovery Raises GBP1.6 Million Via Share Placing

Read more
24 Jan 2020 15:59

UK Shareholder Meetings Calendar - Next 7 Days

UK Shareholder Meetings Calendar - Next 7 Days

Read more
7 Jan 2020 10:40

C4X Discovery Annual Loss Widens, Confident In Strategy

C4X Discovery Annual Loss Widens, Confident In Strategy

Read more
7 Jan 2020 09:59

C4X losses widen as its revenue drops to nil

(Sharecast News) - Drug discovery company C4X Discovery Holdings announced a fall in revenue to nil in its full-year results on Tuesday, from £7.06m in 2018, which the board said as driven entirely by the Indivior licensing agreement in that year.

Read more
31 Dec 2019 10:47

UK Earnings, Trading Statements Calendar - Next 7 Days

UK Earnings, Trading Statements Calendar - Next 7 Days

Read more
24 Oct 2019 17:06

UPDATE: C4X Discovery Raises GBP7 Million In Discounted Placing

UPDATE: C4X Discovery Raises GBP7 Million In Discounted Placing

Read more
24 Oct 2019 11:09

C4X Discovery Raises Over GBP5 Million In Discounted Placing

C4X Discovery Raises Over GBP5 Million In Discounted Placing

Read more
24 Oct 2019 10:31

UK WINNERS & LOSERS SUMMARY: Woodford Trust Up 30% As Schroders Tapped

UK WINNERS & LOSERS SUMMARY: Woodford Trust Up 30% As Schroders Tapped

Read more
1 Oct 2019 10:15

C4X makes solid progress across portfolio of programmes

(Sharecast News) - Drug discovery company C4X Discovery Holdings announced progress across a number of key programmes in line with its strategy on Tuesday, reporting that it was continuing to progress its strategy to deliver programmes for out-licensing its NRF-2 activator, IL-17 inhibitor and LifeArc collaboration.

Read more
27 Sep 2019 15:39

C4X upbeat as its molecule progresses with Indivior

(Sharecast News) - Drug discovery company C4X Discovery Holdings noted an announcement on Friday that the National Institutes of Health (NIH) in the United States has granted Indivior's application titled "Clinical Evaluation of C4X3256, a Non-Opioid, Highly-Selective Orexin-1 Receptor Antagonist for the Treatment of Opioid Use Disorder'.

Read more
2 Sep 2019 12:02

Former Glaxo Vice President To Lead C4X Discovery Advisory Network

(Alliance News) - C4X Discovery Holdings PLC on Monday said it is forming a drug discovery advisory network chaired by "renowned industry veteran" Robin Carr.Shares in C4X were up

Read more
30 Apr 2019 12:59

C4X Discovery Interim Loss Widens, Focuses On Inking Deals

LONDON (Alliance News) - C4X Discovery Holdings PLC said on Tuesday it had a "strong" first half, though its loss widened on higher research and development costs.The drug firm to

Read more
23 Apr 2019 16:03

UK Earnings, Trading Statements Calendar - Next 7 Days

Wednesday 24 April PetropavolskFull Year ResultsBoohoo GroupFull Year HealthFull

Read more
6 Dec 2018 16:04

E-Therapeutics and C4X upbeat on Parkinson's collaboration

(Sharecast News) - Network-driven drug discovery company e-Therapeutics and C4X Discovery Holdings updated the market on their collaboration on Thursday, to identify novel intervention strategies for the potential treatment of Parkinson's Disease (PD).

Read more
6 Dec 2018 09:23

e-Therapeutics And C4X Identify New Pathways For Parkinson's Treatment

LONDON (Alliance News) - C4X Discovery Holdings PLC and e-Therapeutics PLC on Thursday said that, through their collaboration, they discovered additional novel biological pathways for the of that

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.